All Events and PresentationsMay 18, 2025Highly selective and reversible STAT6 inhibition demonstrates potential for differentiated efficacy and safety profile in type 2 allergic inflammationView Poster »May 8, 2025Novel Inhibitors of the BTK SH2 Domain Selectively and Potently Block BTK Signaling and are Efficacious in Preclinical Models of Chronic Spontaneous UrticariaView Poster »February 11, 2025Oppenheimer Healthcare Life Sciences ConferenceAccess Webcast »January 15, 2025J.P. Morgan Healthcare ConferenceView Presentation »December 7, 2023STAT6 Program Highlighted in Sanofi R&D DayAccess Webcast »
